ISIS-APO(a)Rx

antisense oligonucleotide targeting Apo(a) · Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISIS-APO(a)Rx, covering 2019-12-20 to 2019-12-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS-APO(a)Rx in Participants With High Lipoprotein(a) [Phase 2]

See pricing